AVTI Stock Overview
Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Avitar, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000014 |
| 52 Week High | US$0.000014 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 1,300.00% |
| 3 Month Change | n/a |
| 1 Year Change | 1,300.00% |
| 3 Year Change | -97.67% |
| 5 Year Change | -95.33% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| AVTI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1,300.0% | -2.9% | -3.2% |
| 1Y | 1,300.0% | -3.7% | 19.3% |
Return vs Industry: AVTI exceeded the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: AVTI exceeded the US Market which returned 19.3% over the past year.
Price Volatility
| AVTI volatility | |
|---|---|
| AVTI Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AVTI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine AVTI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Cory Gelmon | n/a |
Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit.
Avitar, Inc. Fundamentals Summary
| AVTI fundamental statistics | |
|---|---|
| Market cap | US$10.24k |
| Earnings (TTM) | -US$2.76m |
| Revenue (TTM) | US$2.66m |
0.0x
P/S Ratio0.0x
P/E RatioIs AVTI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVTI income statement (TTM) | |
|---|---|
| Revenue | US$2.66m |
| Cost of Revenue | US$2.04m |
| Gross Profit | US$622.04k |
| Other Expenses | US$3.38m |
| Earnings | -US$2.76m |
Last Reported Earnings
Dec 31, 2007
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did AVTI perform over the long term?
See historical performance and comparison